|
|
Article: Scripps oceanography works with biotechnology companies to develop pharmaceuticals from the sea: heading into new frontiers for institution's second century.(Scripps Institution of Oceanography)
- Article from:
- San Diego Business Journal
- Article date:
- October 20, 2003
CopyrightCOPYRIGHT 2003 CBJ, L.P. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Although the oceans cover 70 percent of the planet's surface, much of their biomedical potential has gone largely unexplored. Until now.
Researchers at Scripps Institution of Oceanography at the University of California, San Diego, have recently shown that sediments in the deep ocean are a significant biomedical resource for microbes that produce antibiotic molecules.
A group led by William Fenical, director of the Center for Marine Biotechnology and Biomedicine (CMBB) at Scripps, discovered bacteria that produce molecules with potential in the treatment of infectious diseases and cancer.
"The average person thinks of the bottom of the ocean as ...
Related newspaper, magazine, and journal articles:
|
|
Article: Nereus Pharmaceuticals Initiates Clinical Trial of ...
PR Newswire;
March 20, 2008 ;
700+ words
... ... DIEGO, March 20 /PRNewswire/ -- Nereus Pharmaceuticals, Inc., a pioneer in drug discovery ... Sethna, President and CEO, Nereus Pharmaceuticals, Inc. Upon successful completion ... changes and neuropathies. About Nereus Pharmaceuticals, Inc. Nereus Pharmaceuticals ...
|
|